StonvexLoading…
StonvexStonvexStonvexCore line items from SES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.71M | $21.00M | $16.44M | $9.32M |
Operating Income | $-17.87M | $-82.61M | $-64.93M | $-46.28M |
Net Income | $-12.10M | $-73.04M | $-56.00M | $-22.65M |
EPS (Diluted) | $-0.04 | $-0.22 | $-0.17 | $-0.11 |
Total Assets | $253.52M | $272.65M | $288.77M | $290.46M |
Total Liabilities | $50.27M | $57.89M | $60.57M | $41.23M |
Cash & Equivalents | $46.94M | $29.54M | $35.27M | $11.76M |
Free Cash Flow OCF − CapEx | $-20.13M | $-61.22M | $-50.10M | $-35.37M |
Shares Outstanding | 332.84M | 365.43M | 330.81M | 330.54M |